Emerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights)

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This research service analyses the trends in the vaccines and therapies segment.

Table of Contents

Emerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Executive SummaryIntroductionIntroduction to VaccinesAn Overview of Current Vaccines Industry Scope and MethodologyScope and Segmentation of the Research ServiceMethodologyEmerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Emerging Vaccine TechnologiesDNA VaccinesIntroductionPolymer Microspheres for DNA Vaccines (USA)DNA-Based HIV Vaccine in Human Trials (USA)Delivering Genetic Material through Nanorods (USA)Monoclonal AntibodiesMonoclonal for GI Cancers (USA)Panel of HGS Monoclonals Block HIV Entry (USA)New Vector SystemsAdenoviral Vector for HIV (Netherlands)Liposomal Gene Delivery System (USA)AdjuvantsHybridon’s Agents Trigger Mucosal Immune Response (USA)Nanotechnology-Based Vaccine Adjuvant (USA)Plant-Based VaccinesRussian HIV Plant-Based Vaccine in Preliminary Stages of Development (Russia)LSBC's Plant-Based HIV and HPV Vaccines in Development (USA)Emerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Novel Vaccine Delivery SystemsInhalation DeliveryTiny Polymer Spheres Deliver Vaccines Directly to the Lungs (USA)Bi-Directional Nasal Device Delivers Drug on Exhalation (Norway)Dry Powder Inhalers for Consistent and Inexpensive Pulmonary Drug Delivery (USA)Simplifying Nasal Route Vaccine Delivery (Denmark)Needle-Free InjectionsAradigm's Intraject in Final Stages of Development (USA)DNA Influenza Vaccine with Novel Delivery Technology (UK)Liquid Jet Injection (USA)Transdermal DeliveryTranscutaneous Immunization (USA)Ultrasonic Energy for Skin Permeation (USA)Oral DeliveryNew Oral Anthrax Vaccine in the Development Stage (UK)Development of a New Oral Vaccine against Diphtheria (Sweden)Prospective Oral Vaccine for Cervical Cancer (China)Emerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Emerging Vaccine ProductsHIV/AIDS VaccinesHIV Vaccine with Therapore Technology in Phase I Trials (USA)BioVex Dendritic Cell Technology for AIDS Vaccine (UK)Transfection Technology for Merck’s HIV Vaccine (USA)Cancer VaccinesP53 Gene Therapeutic Cancer Vaccine (USA)Novel Cancer Vaccine in Phase II Trials (UK)Mologen’s Autologous Cancer Vaccine Looks Good in Clinical Trials (Germany)Biomira Lung Cancer Vaccine Increases Survival (Canada)Novel Approach against Precancerous Cervical Lesions (France)Therion: Anti-Cancer Vaccines Use Multiple Antigen Genes (USA)GVAX Prostate Cancer Vaccine in Phase III Trials (USA)Genzyme: Vaccine Uses Fused Tumor and Dendritic Cells (USA)Infectious Disease VaccinesGSK’s Malaria Vaccine for African Children (USA)TIGR Sequence for Pneumococcus (USA)Chiron Meningococcal B Vaccine for New Zealand (USA)Emerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Development of New Vaccines--Technology AssesmentTrend AnalysisTechnology TrendsCorporate Collaborations (Part I)Corporate Collaborations (Part II)Novel Vaccine Technologies - Drivers and ChallengesDriversChallengesEmerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Key Contacts and Noteworthy PatentsKey ContactsIndustry ContactsUniversity ContactsImportant PatentsPatents (Companies)Patents (Universities)Emerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Frost & Sullivan 2005 Science and Technology AwardsTechnology Innovation AwardAward DescriptionAward RecipientExcellence in TechnologyAward DescriptionAward RecipientExcellence in ResearchAward DescriptionAward RecipientEmerging Vaccines and Therapies--Analysis of Technological Trends (Technical Insights), Critical Reference TablesBiotech ExpenditureNumber of Biotech Companies (1999-2006)Government Investment in Biotech R&D (1999-2006)Private Investment in Biotech (1999-2006)Number of Biotech PatentsUSPTO Biotech Patents (1996-2000)EPO Biotech Patents (1996-2000)HIV Incidence and MortalityHIV Prevalence (1999-2006)AIDS Mortality (1999-2006)Cancer Incidence and MortalityLung Cancer Incidence (1999-2006)Lung Cancer Mortality (1999-2006)Prostate Cancer Incidence (1999-2006)Prostate Cancer Mortality (1999-2006)Infant Mortality and HIB ImmunizationInfant Mortality Rate (1999-2006)HIB Immunization (1999-2006)




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.